1st Quarter - Report

APOTEX CORP. for APOTEX CORP.

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

HR 1908, Patent Reform Act of 2007, Section 12, Additional Information, Inequitable Conduct as a Defense to Infringement S. 1145, Patent Reform Act of 2007, Section 12, Inequitable Conduct

Foreign entity interest: Apotex Holdings Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issue identified in this report.

LobbyistCovered position, as disclosed
STEVEN GIULI —

Contacted: HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Medicare/Medicaid MMM

Centers for Medicare and Medicaid Services Rule 2238-P concerning Medicaid prescription drug reimbursement S. 1951, Fair Medicaid Drug Pricing Act HR 3700, Fair Medicaid Drug Pricing Act HR 3140, Saving our Community Pharmacy Act

Foreign entity interest: Apotex Holdings Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issue identified in this report.

LobbyistCovered position, as disclosed
STEVEN GIULI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC)

Bills named: H.R. 3140 (110th), H.R. 3700 (110th), S. 1951 (110th)

Pharmacy PHA

S. 316, the Preserve Access to Affordable Generics Act HR 1902, the Protecting Consumer Access to Generic Drugs Act HR 1432, the Preserve Access to Affordable Generics Act HR 1038, the Access to Life Savings Medicine Act S. 623, the Access to Life Savings Medicine Act S. 1695, the Biologics Price Competition and Innovation Act S. 1088, Lower Priced Drugs Act HR 3610, the Food and Drug Import Safety Act, Section 4, User Fees Regarding Drug Safety Pharmaceutical pedigree/track and trace issues

Foreign entity interest: Apotex Holdings Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issue identified in this report.

LobbyistCovered position, as disclosed
STEVEN GIULI —

Contacted: Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1695 (110th), H.R. 1038 (110th), H.R. 1902 (110th), S. 623 (110th), H.R. 3610 (110th), S. 316 (110th), S. 1088 (110th), H.R. 1432 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.